biote Corp. (BTMD)

Market Cap	127.38M
Revenue (ttm)	197.19M
Net Income (ttm)	3.16M
Shares Out	36.71M
EPS (ttm)	0.09
PE Ratio	38.56
Forward PE	8.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70,554
Open	3.590
Previous Close	3.480
Day's Range	3.415 - 3.590
52-Week Range	3.040 - 8.440
Beta	1.18
Analysts	Strong Buy
Price Target	8.00 (+130.55%)
Earnings Date	May 6, 2025

About BTMD

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice m...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2012
• Employees: 217
• Stock Exchange: NASDAQ
• Ticker Symbol: BTMD
• Website: https://www.biote.com

Financial Performance

In 2024, biote's revenue was $197.19 million, an increase of 6.38% compared to the previous year's $185.36 million. Earnings were $3.16 million, a decrease of -4.79%.

Analyst Forecast

According to one analyst, the rating for BTMD stock is "Strong Buy" and the 12-month stock price forecast is $8.0.

Price Target

$8.0

(130.55% upside)

Analyst Consensus: Strong Buy